Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 2.18
-3.11 %
$ 272 M
Market Cap
-0.44
P/E
1. INTRINSIC VALUE
FINANCIALS
Balance Sheet
Canopy Growth Corporation
| Current Assets | 371 M |
| Cash & Short-Term Investments | 203 M |
| Receivables | 44.9 M |
| Other Current Assets | 123 M |
| Non-Current Assets | 929 M |
| Long-Term Investments | 136 M |
| PP&E | 320 M |
| Other Non-Current Assets | 473 M |
| Current Liabilities | 235 M |
| Accounts Payable | 28.7 M |
| Short-Term Debt | 119 M |
| Other Current Liabilities | 86.9 M |
| Non-Current Liabilities | 565 M |
| Long-Term Debt | 549 M |
| Other Non-Current Liabilities | 16.2 M |
EFFICIENCY
Earnings Waterfall
Canopy Growth Corporation
| Revenue | 297 M |
| Cost Of Revenue | 216 M |
| Gross Profit | 80.9 M |
| Operating Expenses | 310 M |
| Operating Income | -229 M |
| Other Expenses | 255 M |
| Net Income | -484 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Canopy Growth Corporation
| Net Income | -484 M |
| Depreciation & Amortization | 53.2 M |
| Capital Expenditures | -4 M |
| Stock-Based Compensation | 14.2 M |
| Change in Working Capital | 3.97 M |
| Others | 116 M |
| Free Cash Flow | -286 M |
Wall Street Analysts Price Targets
Canopy Growth Corporation
Wall Street analysts predict an average 1-year price target for CGC of $17.7 , with forecasts ranging from
a
low of
$8 to a high of $35 .
CGC Lowest Price Target
Wall Street Target
8 USD
266.97%
CGC Average Price Target
Wall Street Target
17.7 USD
710.78%
CGC Highest Price Target
Wall Street Target
35 USD
1505.50%
4. DIVIDEND
ANALYSIS
CGC does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Canopy Growth Corporation
Sold
0-3 MONTHS
24.1 K USD 4
3-6 MONTHS
939 K USD 7
6-9 MONTHS
224 K USD 6
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
2 weeks ago
Dec 31, 2024
|
Sell 5.35 K
USD
|
Kruh Willy
Director
|
- 2004
|
2.67 USD |
|
2 weeks ago
Dec 31, 2024
|
Sell 5.33 K
USD
|
Yanofsky Theresa
Director
|
- 1996
|
2.67 USD |
|
2 weeks ago
Dec 31, 2024
|
Sell 5.35 K
USD
|
Mongeau Luc
Director
|
- 2004
|
2.67 USD |
|
2 weeks ago
Dec 31, 2024
|
Sell 8.03 K
USD
|
Lazzarato David Angelo
Director
|
- 3006
|
2.67 USD |
|
3 months ago
Sep 30, 2024
|
Sell 9.88 K
USD
|
Kruh Willy
Director
|
- 1995
|
4.95 USD |
|
3 months ago
Sep 30, 2024
|
Sell 9.84 K
USD
|
Yanofsky Theresa
Director
|
- 1987
|
4.95 USD |
|
3 months ago
Sep 30, 2024
|
Sell 9.88 K
USD
|
Mongeau Luc
Director
|
- 1995
|
4.95 USD |
|
3 months ago
Sep 30, 2024
|
Sell 14.8 K
USD
|
Lazzarato David Angelo
Director
|
- 2993
|
4.95 USD |
|
4 months ago
Aug 22, 2024
|
Sell 335 K
USD
|
Klein David Eric
Chief Executive Officer
|
- 40135
|
8.35 USD |
|
4 months ago
Aug 22, 2024
|
Sell 140 K
USD
|
Gedeon Christelle
See Remarks
|
- 16788
|
8.35 USD |
|
4 months ago
Aug 22, 2024
|
Sell 419 K
USD
|
Hong Judy Eun Joo
Chief Financial Officer
|
- 50188
|
8.35 USD |
|
6 months ago
Jun 28, 2024
|
Sell 12.7 K
USD
|
Yanofsky Theresa
Director
|
- 1983
|
6.41 USD |
|
6 months ago
Jun 28, 2024
|
Sell 12.9 K
USD
|
Mongeau Luc
Director
|
- 2012
|
6.41 USD |
|
6 months ago
Jun 28, 2024
|
Sell 19.1 K
USD
|
Lazzarato David Angelo
Director
|
- 2986
|
6.41 USD |
|
6 months ago
Jun 28, 2024
|
Sell 12.9 K
USD
|
Kruh Willy
Director
|
- 2012
|
6.41 USD |
|
7 months ago
Jun 10, 2024
|
Sell 37.2 K
USD
|
Kruh Willy
Director
|
- 3738
|
9.94 USD |
|
7 months ago
Jun 10, 2024
|
Sell 17.7 K
USD
|
Klein David Eric
Chief Executive Officer
|
- 1779
|
9.94 USD |
|
7 months ago
Jun 10, 2024
|
Sell 447
USD
|
Hong Judy Eun Joo
Chief Financial Officer
|
- 45
|
9.94 USD |
|
7 months ago
Jun 10, 2024
|
Sell 36.7 K
USD
|
Yanofsky Theresa
Director
|
- 3692
|
9.94 USD |
|
7 months ago
Jun 10, 2024
|
Sell 37.2 K
USD
|
Mongeau Luc
Director
|
- 3745
|
9.94 USD |
|
7 months ago
Jun 10, 2024
|
Sell 36.8 K
USD
|
Lazzarato David Angelo
Director
|
- 3707
|
9.94 USD |
|
1 year ago
Dec 29, 2023
|
Sell 24.7 K
USD
|
Yanofsky Theresa
Director
|
- 3697
|
6.68 USD |
|
1 year ago
Dec 29, 2023
|
Sell 24.8 K
USD
|
Lazzarato David Angelo
Director
|
- 3713
|
6.68 USD |
|
1 year ago
Nov 20, 2023
|
Sell 31.2 K
USD
|
Lazzarato David Angelo
Director
|
- 38502
|
0.81 USD |
|
1 year ago
Nov 20, 2023
|
Sell 31.1 K
USD
|
Yanofsky Theresa
Director
|
- 38344
|
0.81 USD |
|
1 year ago
Nov 20, 2023
|
Sell 15 K
USD
|
SCHMELING JUDY
Director
|
- 18481
|
0.81 USD |
|
1 year ago
Sep 01, 2023
|
Sell 27.7 K
USD
|
Lazzarato David Angelo
Director
|
- 38963
|
0.71 USD |
|
1 year ago
Sep 01, 2023
|
Sell 13.3 K
USD
|
SCHMELING JUDY
Director
|
- 18703
|
0.71 USD |
|
1 year ago
Sep 01, 2023
|
Sell 27.6 K
USD
|
Yanofsky Theresa
Director
|
- 38803
|
0.71 USD |
|
1 year ago
Jun 27, 2023
|
Sell 2.4 K
USD
|
Lazzarato David Angelo
Director
|
- 3872
|
0.62 USD |
|
1 year ago
Jun 27, 2023
|
Sell 12.2 K
USD
|
Stewart Thomas Carlton
Chief Accounting Officer
|
- 19667
|
0.62 USD |
|
1 year ago
Jun 30, 2023
|
Sell 9.76 K
USD
|
Klein David Eric
Chief Executive Officer
|
- 18775
|
0.52 USD |
|
1 year ago
Jun 27, 2023
|
Sell 2.39 K
USD
|
Yanofsky Theresa
Director
|
- 3856
|
0.62 USD |
|
1 year ago
Jun 27, 2023
|
Sell 1.15 K
USD
|
SCHMELING JUDY
Director
|
- 1859
|
0.62 USD |
|
1 year ago
Jun 30, 2023
|
Sell 565
USD
|
Hong Judy Eun Joo
Chief Financial Officer
|
- 1087
|
0.52 USD |
|
2 years ago
Dec 28, 2022
|
Sell 11 K
USD
|
Yanofsky Theresa
Director
|
- 3717
|
2.97 USD |
|
2 years ago
Dec 28, 2022
|
Sell 11.1 K
USD
|
Lazzarato David Angelo
Director
|
- 3733
|
2.97 USD |
|
2 years ago
Dec 28, 2022
|
Sell 5.32 K
USD
|
SCHMELING JUDY
Director
|
- 1792
|
2.97 USD |
|
2 years ago
Jun 09, 2022
|
Sell 5.08 K
USD
|
Hong Judy Eun Joo
Chief Financial Officer
|
- 1021
|
4.98 USD |
|
2 years ago
Jun 09, 2022
|
Sell 1.4 K
USD
|
Stewart Thomas Carlton
Chief Accounting Officer
|
- 281
|
4.98 USD |
|
4 years ago
Aug 13, 2020
|
Sell 1.69 M
USD
|
Shipley Tomas IV
See Remarks
|
- 73333
|
23.1 USD |
|
4 years ago
Nov 13, 2020
|
Sell 2.72 M
USD
|
Kovacevic Rade Nikola
President
|
- 86666
|
31.38 USD |
|
4 years ago
Nov 12, 2020
|
Sell 4.75 M
USD
|
Kovacevic Rade Nikola
President
|
- 150000
|
31.65 USD |
|
4 years ago
Nov 13, 2020
|
Sell 1.82 K
USD
|
Kovacevic Rade Nikola
President
|
- 58
|
31.41 USD |
|
4 years ago
Nov 13, 2020
|
Sell 135 K
USD
|
Kovacevic Rade Nikola
President
|
- 4314
|
31.4 USD |
|
4 years ago
Nov 12, 2020
|
Sell 2.17 M
USD
|
Shaer Phillip Stephen
Chief Legal Officer
|
- 70000
|
31.03 USD |
|
20 years ago
Dec 28, 2004
|
Bought
10.7 K USD
|
BOGGS SCOTT M
Director
|
+ 500
|
21.45 USD |
7. News
Top Canadian Cannabis Stocks to Watch for Breakout Opportunities in 2025
The Canadian cannabis market remains a focal point for investors, driven by innovation and expansion into U.S. and global markets. As the U.S. cannabis industry is projected to surpass $41 billion in annual sales by 2025, Canadian companies are positioning themselves for growth. Recent legislative developments in the U.S., including discussions about federal legalization, have bolstered market optimism. These changes could pave the way for Canadian firms to expand operations or form strategic partnerships. Notably, companies like Tilray and Canopy Growth are diversifying portfolios to include U.S. hemp, CBD, and beverage markets, showcasing their adaptability.
marijuanastocks.com
- 1 week ago
Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President
A cannabis and beverage alcohol industry executive with more than 25 years of experience, Mr. Jorgensen will lead the unified Canopy USA organization forward with a focus on driving profitable growth across the U.S. With the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA now enters a new chapter of growth across key segments including flower, edibles, vapes, extracts, and through an established retail presence in high potential markets across the Midwest and Northeast BOULDER, Colo.
prnewswire.com
- 1 week ago
Canopy Growth Corporation (CGC) Flat As Market Sinks: What You Should Know
In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $2.74, denoting no change from the preceding trading day.
zacks.com
- 2 weeks ago
Top Canadian Marijuana Stocks For Your 2025 Watchlist
Most marijuana stock investors are excited about the upcoming trading year. 2025 has lots of potential in various fashions that are keeping hopes high for investors and legal operators. To start there has been an increase in demand for more cannabis products. As well as more companies turning higher profits and breaking records almost every quarter. What this does is show others that the cannabis sector regardless of its downtrend is a space where ultimately money can be made. Yet with the large amount of volatile trading, it's been tough to take profits.
marijuanastocks.com
- 3 weeks ago
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
zacks.com
- 3 weeks ago
Canadian Gold Corp. Closes Final Tranche of Financing
Toronto, Ontario--(Newsfile Corp. - December 24, 2024) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") announces the completion of the final tranche closing of its private placement offering, resulting in aggregate oversubscribed proceeds of $775,089. On December 13, 2024, the Company announced the first tranche closing of $500,000 by the issuance of 2,631,579 flow through shares at a price of $0.19 per share.
newsfilecorp.com
- 3 weeks ago
Why Canopy Growth Corporation (CGC) Outpaced the Stock Market Today
In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $2.87, denoting a +1.41% change from the preceding trading day.
zacks.com
- 3 weeks ago
Top Marijuana Stocks For Investors 2025
Marijuana stock investors are always looking for the next opportunity. Whether short or long-term gains the goal is to make money. The cannabis industry has seen its fair share of volatility both in the legal market and public sector. Even with how things are now there are many ways to enter the market. Cannabis has been on an uptrend in popularity and growing consumer demand.
marijuanastocks.com
- 1 month ago
Canadian Gold Corp. Commences Phase 4 Drill Program at Tartan Mine
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce the commencement of its Phase 4 drill program at the Tartan Mine located near Flin Flon, Manitoba. Phase 4 Exploration Program The Company's Phase 4 drill program will look to build upon the success of the previous phases that have significantly expanded the mineralization at depth since the 2017 resource estimate (Fig.
newsfilecorp.com
- 1 month ago
Canadian Gold Corp. Closes First Tranche of Financing
Toronto, Ontario--(Newsfile Corp. - December 13, 2024) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce an initial first tranche closing of its private placement offering, by the issuance of 2,631,579 flow through shares at a price of $0.19 per share, for gross proceeds totalling $500,000. In connection with this first tranche closing, the Company paid $12,000 in finders fees to eligible finders, and all securities issued are subject to a hold period of four months.
newsfilecorp.com
- 1 month ago
STORZ & BICKEL Makes History as First Vaporizer Brand to Sponsor NYLON House During Miami Art Week
The Brand's Latest Device, VENTY, Crowned Vaporizer of the Year at the 2024 EMJAYS International Cannabis Awards TUTTLINGEN, Germany , Dec. 12, 2024 /PRNewswire/ -- STORZ & BICKEL GmbH (" STORZ & BICKEL "), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), made history during Miami Art Week 2024 as the first vaporizer brand to sponsor NYLON House, hosted by Camila Cabello featuring a live performance from Ludacris and a DJ set by Hugel. Simultaneously, the brand's latest device—the VENTY —won vaporizer of the year at the EMJAYS International Cannabis Awards.
prnewswire.com
- 1 month ago
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
zacks.com
- 1 month ago
8. Profile
Summary
Canopy Growth Corporation CGC
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 272 M
Dividend Yield
0.00%
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Contact
1 Hershey Drive, Smiths Falls, ON, K7A 0A8
https://www.canopygrowth.com
IPO
Date
April 7, 2014
Employees
1029
Officers
Dr. Christelle Gedeon L.L.B., Ph.D.
Chief Legal Officer & Corporate Secretary
Ms. Jenny Brewer
Chief Human Resources Officer
Mr. Jurgen Bickel
MD and Co-Founder of STORZ & BICKEL GmbH
Mr. Tyler Burns
Director of Investor Relations
Ms. Judy Eunjoo Hong
Chief Financial Officer & Principal Accounting Officer
Jason Green
Head of Agriculture - Hemp Division
Ms. Tara Rozalowsky
Chief Growth Officer & President of International
Mr. Dave Paterson
President of Canada